Health Care Equipment

Acutus Medical

EnChannel Medical Acquires Acutus Medical's ACQMAP Assets

Acutus Medical released FY2024 annual earnings on March 24 (EST), actual revenue 20.16 M USD (forecast 35.36 M USD), actual EPS -0.3207 USD (forecast -2.19 USD)

Acutus Medical released FY2024 Q4 earnings on March 24 (EST), actual revenue 7.13 M USD (forecast 11.1 M USD), actual EPS -0.0472 USD (forecast -0.53 USD)

Acutus Medical released FY2024 cumulative Q3 earnings on November 14, 2024 (EST), with actual revenue of 13.02M USD and EPS of -0.2734

Acutus Medical released FY2024 Q3 earnings on November 14 (EST), actual revenue 5.266 MUSD (forecast 9.36 MUSD), actual EPS -0.1881 USD (forecast -0.54 USD)

Acutus Medical released FY2023 Q4 earnings on April 1 (EST), actual revenue 2.348 M USD (forecast 6.629 M USD), actual EPS -1.152 USD (forecast -0.62 USD)

Acutus Medical released FY2023 annual earnings on April 1, 2024 (EST), actual revenue 7.164 M USD (forecast 20.8 M USD), actual EPS -2.8067 USD (forecast -2.48 USD)

A SPAC III Acquisition

PicoCELA

Davis Commodities

Society Pass

ECD Automotive Design

Gauzy

Bristol-Myers Squibb Company

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

Paranovus ENT Tech

Cue BioPharma

Delcath

Electromed

Abbott Laboratories

Intuitive Surgical

Boston Scientific

Stryker

IDEXX Labs

Edwards Lifesciences

Resmed

DexCom

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap